Work

Synergy with combination of AKT inhibitor (MK-2206) and paclitaxel in head and neck squamous cell carcinoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e13532

Authors: Omar Ahmed, Wen-Liang Kuo, Madhavi Nagilla, Jeannette S. Messer, David L. Boone, Marina Sharifi, Kay Macleod, Ezra E.W. Cohen

Institutions: University of Chicago, University of Chicago Medical Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2605097697

Cites:

Cited by: 4

Related to: 10